A glimmer of hope emerges in the fight against tuberculosis (TB), but the battle is far from over. The World Health Organization (WHO) has reported a significant drop in global TB rates, marking a positive turn after years of setbacks. However, this progress is just the beginning, and there's a long road ahead to meet the ambitious targets set for 2030.
The latest WHO report reveals a 2% decline in TB illness rates from 2023 to 2024, a welcome change after three consecutive years of increases due to the Covid-19 pandemic's impact on healthcare systems. Most indicators are now moving in the right direction, but the agency emphasizes that we're still not on track to meet the 2030 goals outlined in the End TB Strategy, adopted in 2014-2015.
This strategy aims to drastically reduce TB incidence, deaths, and patient costs by 2025, 2030, and beyond. In 2024, TB claimed the lives of 1.23 million people, a 29% decrease from 2015. While this is a step in the right direction, it falls short of the 75% reduction target set for 2025 and the 90% goal for 2030.
Dr. Tereza Kasaeva, director of WHO's division for tuberculosis, HIV, and related infections, highlights a critical obstacle: stagnant global funding for TB since 2020. She warns that modeling studies predict up to 2 million additional deaths and 10 million new TB cases between 2025 and 2035 if international donor funding continues to be cut.
And here's where it gets controversial: the United States' withdrawal from the WHO in January, citing alleged mismanagement, has created a multi-billion-dollar gap in the agency's budget for 2026-2027, leading to a 21% cut in proposed spending. This decision has had a significant impact on critical international aid, especially from the US Agency for International Development, which has been instrumental in preventing millions of TB-related deaths.
According to WHO, the US aid helped avert approximately 3.65 million deaths from TB in 2024 alone. Medecins Sans Frontieres, a global medical charity, warns that children will bear the brunt of these aid cuts, as they already face significant challenges in accessing TB care.
Despite these challenges, the WHO highlights the continued support of the Geneva-based Global Fund to Fight AIDS, Tuberculosis, and Malaria, which remains the largest international donor for low- and middle-income countries.
So, while we celebrate the initial decline in TB rates, the question remains: Can we sustain and accelerate this progress without adequate funding? What are your thoughts on the impact of international aid cuts on global health initiatives? Feel free to share your opinions and engage in the discussion below!
